These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3008580)
1. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Collier AC; Barnes RC; Handsfield HH Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580 [TBL] [Abstract][Full Text] [Related]
2. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [TBL] [Abstract][Full Text] [Related]
3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973 [TBL] [Abstract][Full Text] [Related]
4. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men. Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805 [TBL] [Abstract][Full Text] [Related]
5. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822 [TBL] [Abstract][Full Text] [Related]
6. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772 [TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Melbye M; Biggar RJ; Ebbesen P; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA Br Med J (Clin Res Ed); 1984 Sep; 289(6445):573-5. PubMed ID: 6087972 [TBL] [Abstract][Full Text] [Related]
8. Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Evans BA; Dawson SG; McLean KA; Teece SA; Key PR; Bond RA; Macrae KD; Jesson WJ; Mortimer PP Genitourin Med; 1986 Dec; 62(6):384-9. PubMed ID: 3469139 [TBL] [Abstract][Full Text] [Related]
9. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375 [TBL] [Abstract][Full Text] [Related]
10. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729 [TBL] [Abstract][Full Text] [Related]
11. Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan. Tsuchie H; Kurimura T; Hinuma Y J Infect; 1985 May; 10(3):272-6. PubMed ID: 2993425 [TBL] [Abstract][Full Text] [Related]
12. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study. Jaffe HW; Darrow WW; Echenberg DF; O'Malley PM; Getchell JP; Kalyanaraman VS; Byers RH; Drennan DP; Braff EH; Curran JW Ann Intern Med; 1985 Aug; 103(2):210-4. PubMed ID: 2990275 [TBL] [Abstract][Full Text] [Related]
13. The AIDS epidemic. Landesman SH; Ginzburg HM; Weiss SH N Engl J Med; 1985 Feb; 312(8):521-5. PubMed ID: 2982097 [TBL] [Abstract][Full Text] [Related]
14. Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London. Carne CA; Weller IV; Sutherland S; Cheingsong-Popov R; Ferns RB; Williams P; Mindel A; Tedder R; Adler MW Lancet; 1985 Jun; 1(8440):1261-2. PubMed ID: 2860454 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to HTLV-III/LAV in a population attending a sexually transmitted diseases clinic. Rabkin CS; Thomas PA; Jaffe HW; Schultz S Sex Transm Dis; 1987; 14(1):48-51. PubMed ID: 3645806 [TBL] [Abstract][Full Text] [Related]
16. The epidemiology and prevention of the acquired immunodeficiency syndrome. Curran JW Ann Intern Med; 1985 Nov; 103(5):657-62. PubMed ID: 2996395 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire. Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178 [TBL] [Abstract][Full Text] [Related]
18. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389 [TBL] [Abstract][Full Text] [Related]
19. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy]. Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134 [TBL] [Abstract][Full Text] [Related]
20. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Gazzard BG; Shanson DC; Farthing C; Lawrence AG; Tedder RS; Cheingsong-Popov R; Dalgleish A; Weiss RA Lancet; 1984 Sep; 2(8401):480-3. PubMed ID: 6147547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]